Simplex Trading
BCTX

Simplex Trading’s Briacell Therapeutics BCTX Stock Holding History

Simplex Trading’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-277
Closed -$1K – 8528
2024
Q4 		$1K Buy
277
+14
+5% +$1.68K ﹤0.01% 8150
2024
Q3 		$48K Sell
263
-36
-12% -$4.04K ﹤0.01% 5911
2024
Q2 		$51K Sell
299
-52
-15% -$14.7K ﹤0.01% 6054
2024
Q1 		$150K Buy
351
+230
+190% +$127K ﹤0.01% 5153
2023
Q4 		$29K Buy
121
+20
+20% +$14.3K ﹤0.01% 6577
2023
Q3 		$5K Buy
+101
New +$98.9K ﹤0.01% 7611

Other funds holding BCTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $770M AUM 18.25% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HWA
HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return

Simplex Trading's BCTX Position: Q4 2024 in Review

Simplex Trading sold out of Briacell Therapeutics (BCTX) in Q4 2024, closing a stake of 2 shares — an estimated $240 sold.

Simplex Trading first reported a position in BCTX in Q4 2021 and held it in 8 quarters. The position peaked at $260K in Q1 2022. 25 funds tracked by Wall St. Rank hold BCTX as of Q4 2024.

  • Simplex Trading reported no remaining Briacell Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 2 Briacell Therapeutics shares in Q4 2024, an estimated $240.
  • Simplex Trading first reported a position in Briacell Therapeutics in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's Briacell Therapeutics position peaked at $260K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.